Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

How Should Physicians and Patients Choose Between Alternative Therapies for NVAF and Iatrogenic Stroke? The Essence of Shared Decision-making

Presenter: James B. Hermiller Jr, Saibal Kar, Megan Coylewright

June 23, 2018

Presentation The Structural Heart Disease Summit 2018

Beyond Iatrogenic Stroke: PFO Closure for Migraine and More

Presenter: John D. Carroll, Brij Maini, Robert J. Sommer

June 23, 2018

Presentation The Structural Heart Disease Summit 2018

Data Deliverance: Updated PFO Closure for Cryptogenic Stroke Clinical Trial Review and Guidelines

Presenter: John D. Carroll, Brij Maini, Lars Sondergaard

June 23, 2018

Presentation The Structural Heart Disease Summit 2018

An Integrated Strategy to Prevent Both Ischemic and Hemorrhagic Strokes

Presenter: Robert J. Sommer, Brian K. Whisenant, Rajan Gadhia

June 23, 2018

Presentation The Structural Heart Disease Summit 2018

Surgical Approaches and Emerging Data for LAA Closure: Are the Results Robust?

Presenter: Anthony N. DeMaria, Vivek Y. Reddy, Subhasis Chatterjee

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Electrical Approaches to NVAF in 2018 (Standalone or in Combination With LAA Occlusion): Evidence and Practical Recommendations

Presenter: Anthony N. DeMaria, Vivek Y. Reddy, Shephal Doshi

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Atrial Fibrillation + PCI: The Myths and Realities of Triple Therapy

Presenter: Anthony N. DeMaria, Vivek Y. Reddy, Ashish Pershad

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Pharmacologic Agents to Prevent Stroke in Nonvalvular Atrial Fibrillation and PFO: Evidence and Real-world Practices

Presenter: Anthony N. DeMaria, Vivek Y. Reddy, Gregg W. Stone

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Cardioembolic Stroke: Scope, Etiologies, Guidelines, and Uncertainties

Presenter: Anthony N. DeMaria, Vivek Y. Reddy, Rajan Gadhia

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

NO: The Data Are Weak and the Costs Are Prohibitive!

Presenter: John K. Forrest

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

YES: Review of ALL the Data and Common Sense Tell the Story!

Presenter: Axel Linke

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Presenter: Eberhard Grube, Tamim Nazif

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Cedars-Sinai Medical Center (USA)

Presenter: Tarun Chakravarty

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

A Rare Cause of Stroke After TAVR: Foreign Body

Presenter: Ashish Pershad, Abhishek Bhagat, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Erasmus University (The Netherlands)

Presenter: Nicolas M. Van Mieghem

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Ulm University (Germany)

Presenter: Julia Seeger

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Cost-effectiveness of Cerebral Protection During TAVR: Can We Justify Systematic Use?

Presenter: Eberhard Grube, Tamim Nazif, Hemal Gada

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Strokes After Transfemoral TAVR vs SAVR: A Propensity-Matched Analysis From the PARTNER Trial

Presenter: Eberhard Grube, Tamim Nazif, Chetan P. Huded

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Strokes After TAVR (and SAVR): Incidence in the "Modern Era" and Key Messages From NeuroARC

Presenter: Eberhard Grube, Tamim Nazif, Alexandra J. Lansky

June 21, 2018

Advertisement

How Should Physicians and Patients Choose Between Alternative Therapies for NVAF and Iatrogenic Stroke? The Essence of Shared Decision-making

Beyond Iatrogenic Stroke: PFO Closure for Migraine and More

Data Deliverance: Updated PFO Closure for Cryptogenic Stroke Clinical Trial Review and Guidelines

An Integrated Strategy to Prevent Both Ischemic and Hemorrhagic Strokes

Surgical Approaches and Emerging Data for LAA Closure: Are the Results Robust?

Electrical Approaches to NVAF in 2018 (Standalone or in Combination With LAA Occlusion): Evidence and Practical Recommendations

Atrial Fibrillation + PCI: The Myths and Realities of Triple Therapy

Pharmacologic Agents to Prevent Stroke in Nonvalvular Atrial Fibrillation and PFO: Evidence and Real-world Practices

Cardioembolic Stroke: Scope, Etiologies, Guidelines, and Uncertainties

NO: The Data Are Weak and the Costs Are Prohibitive!

YES: Review of ALL the Data and Common Sense Tell the Story!

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Cedars-Sinai Medical Center (USA)

A Rare Cause of Stroke After TAVR: Foreign Body

Erasmus University (The Netherlands)

Ulm University (Germany)

Cost-effectiveness of Cerebral Protection During TAVR: Can We Justify Systematic Use?

Strokes After Transfemoral TAVR vs SAVR: A Propensity-Matched Analysis From the PARTNER Trial

Strokes After TAVR (and SAVR): Incidence in the "Modern Era" and Key Messages From NeuroARC

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content